| Name | Title | Contact Details |
|---|
Autism Family Center fulfills a critical need for a coordinated, multidisciplinary approach to treating Autistic Disorder by providing a full range of services including Applied Behavior Analysis (ABA). Because we view families as an integrated system and believe that the health of every member is vital for each member to thrive, Autism Family Center provides support services for the entire family. Our process is designed to ensure maximum learning, unity and happiness.
Graham Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Graham Hospital is based in Canton, IL. You can find more information on Graham Hospital at www.grahamhospital.org
Data R X Management is a Cumming, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Homeward is rearchitecting rural health and care for the 60 million Americans living in rural communities. Homeward employs a multidisciplinary care team, available both virtually and on the ground via mobile care units, with in-home remote monitoring to better connect patients to high-quality, affordable and comprehensive care. Today, the company partners with Medicare Advantage plans, taking on the full risk of their members to improve outcomes and reduce costs.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.